SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix's high-profile Nasdaq debut is driving intense market conversation, with traders debating whether the stock's significant ADR premium and volatile entry valuation offer a long-term opportunity or represent an overhyped exit for institutional sellers. The community is heavily focused on the company's role as a dominant memory supplier for AI infrastructure, while many investors are also discussing the potential for short-term price manipulation and how the listing could impact existing semiconductor sector benchmarks like Micron.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending as investors digest blockbuster monthly sales figures alongside active discussions about the company's critical role in the global AI hardware supply chain and geopolitical risks. The community is heavily focused on how TSMC's manufacturing capacity dictates the growth trajectory of major AI players, while traders weigh the impact of potential chip export curbs and foundry pricing updates on the stock's long-term outlook.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing significant volatility and heavy trading volume as investors react to the broader semiconductor sector's performance and anticipate the upcoming July 15th stock split. The community remains deeply divided, with many traders debating the impact of the pending SK Hynix US listing while others express concern over the stock's decoupled price action and potential for continued downward pressure.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending as investors weigh the significance of its new manufacturing joint venture with Toyota, which aims to scale commercial production of electric air taxis, against lingering market concerns regarding high cash burn and ongoing legal disputes. The community remains deeply divided, with bulls pointing to the company's strong institutional backing and FAA certification progress, while skeptics focus on persistent short interest and the long-term dilution risks inherent in the pre-revenue eVTOL sector.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as investors debate whether the current price represents a compelling fundamental discount or a stagnant value trap, with the community closely tracking its struggle to break out of its recent trading range. Discussion is driven by a split between long-term bulls highlighting platform growth and ecosystem expansion, and active traders focusing on intraday volatility, short-term price manipulation, and the impact of broader market macro conditions.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is trending as investors debate its long-term potential following recent institutional expansion news and the launch of new B2B services. While bulls see a setup for a breakout and potential short squeeze driven by retail activity and institutional accumulation, bears remain skeptical, citing market manipulation concerns and persistent downward pressure compared to sector peers.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened community discussion as traders monitor the company's progress on scaling production for its optical interposer technology amidst a broader semiconductor sector pullback. Investors are actively debating the timing of H2 production ramps and potential customer updates, while watching institutional positioning as the firm moves to solidify its manufacturing capacity.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is seeing renewed investor attention following the FDA's acceptance of sNDA filings for its Duchenne Muscular Dystrophy therapies, with a target action date set for early 2027. Despite persistent community debate regarding the company's valuation, leadership, and the impact of trial endpoint misses, the stock remains a focal point for traders speculating on potential M&A activity and long-term pipeline potential.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently experiencing intense volatility driven by broader sector headwinds and market reactions to competitor IPOs, while investors remain closely focused on the long-term potential of the Neutron rocket and recent strategic acquisitions. The community is sharply divided, with some utilizing the recent pullback as an accumulation opportunity based on strong backlog and institutional analyst support, while others express frustration over downward momentum and insider share sales.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending as investors weigh its pivot toward AI/HPC data center infrastructure and a recent 1,200-acre land acquisition in Texas against concerns over executive compensation and a lack of signed tenant contracts. While some in the community see the 4.8 GW power pipeline as a transformative long-term infrastructure play, others are increasingly frustrated by high share volatility, dilution fears, and the company's reliance on Bitcoin market cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?

Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential...

Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's  What You Should Know

The mean of analysts' price targets for Janux Therapeutics (JANX) points to a 155.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Here's Why You Should Add JANX Stock to Your Portfolio Now

Janux Therapeutics advances multiple oncology and immune therapy programs with key clinical updates, new studies and expanded partnerships with BMY and MRK.

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

Janux Therapeutics (JANX) delivered earnings and revenue surprises of +21.83% and -75.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today reported financial results for the quarter...

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

The consensus price target hints at an 180.4% upside potential for Janux Therapeutics (JANX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Janux Therapeutics (NASDAQ:JANX) Upgraded by Truist Financial to Strong-Buy Rating

Truist Financial upgraded Janux Therapeutics to a "strong-buy" rating in a research report on Monday...

JonesTrading Has Lowered Expectations for Janux Therapeutics (NASDAQ:JANX) Stock Price

JonesTrading cut their price target on shares of Janux Therapeutics from $50.00 to $28.00 and set a "buy" rating on the stock in a report on Tuesday...

JANX Stock Edges Up After Hours After Discontinuing Cancer Program In Favor Of Remaining Pipeline

Equity

The company said that it came to the decision after completing early-stage trials across multiple solid tumor indications and an internal review of the data.

Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that it will discontinue further...

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Janux Therapeutics Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$16.40
Prev Close	$16.75
Open	$16.77
Dividend Yield	0.00%
50-Day Moving Average	$14.47
Beta	1.38
Avg. Volume	1.32M
PE Ratio	-8.90

52-Week High	$35.34
52-Week Low	$12.12
Market Capitalization	$1B
EPS (Annual)	-$1.83
Price to Book	1.06
Revenue Per Employee	$91,743.12

Feed

News

Sentiment

Earnings

Fundamentals

Info

JANXJanux Therapeutics Inc

Latest JANX News